These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29415431)

  • 21. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections.
    Uyttebroek S; Bessems L; Metsemakers W-J; Debaveye Y; Van Gerven L; Dupont L; Depypere M; Wagemans J; Lavigne R; Merabishvili M; Pirnay J-P; Devolder D; Spriet I; Onsea J
    Microbiol Spectr; 2023 Dec; 11(6):e0290723. PubMed ID: 37819122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
    Hill C; Mills S; Ross RP
    Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.
    Azam AH; Tanji Y
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2121-2131. PubMed ID: 30680434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The forgotten tale of Brazilian phage therapy.
    Almeida GMF; Sundberg LR
    Lancet Infect Dis; 2020 May; 20(5):e90-e101. PubMed ID: 32213334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal Models to Translate Phage Therapy to Human Medicine.
    Brix A; Cafora M; Aureli M; Pistocchi A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage Therapy in the Postantibiotic Era.
    Gordillo Altamirano FL; Barr JJ
    Clin Microbiol Rev; 2019 Apr; 32(2):. PubMed ID: 30651225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.
    Blanco C; Chen IA
    Phys Biol; 2019 Jul; 16(5):054001. PubMed ID: 31266001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering Phage Products to Combat Antibiotic Resistance in Developing Countries: Lessons Learned from the HIV/AIDS Epidemic in Africa.
    Nagel TE
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29954053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?
    Brüssow H
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636
    [No Abstract]   [Full Text] [Related]  

  • 33. Phage therapy: Current status and perspectives.
    Górski A; Międzybrodzki R; Węgrzyn G; Jończyk-Matysiak E; Borysowski J; Weber-Dąbrowska B
    Med Res Rev; 2020 Jan; 40(1):459-463. PubMed ID: 31062882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the whole standard operating procedure for phage therapy in clinical practice.
    Cui Z; Guo X; Feng T; Li L
    J Transl Med; 2019 Nov; 17(1):373. PubMed ID: 31727099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phages of life - the path to pharma.
    Forde A; Hill C
    Br J Pharmacol; 2018 Feb; 175(3):412-418. PubMed ID: 29266197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The applications of animal models in phage therapy: An update.
    Mehmood Khan F; Manohar P; Singh Gondil V; Mehra N; Kayode Oyejobi G; Odiwuor N; Ahmad T; Huang G
    Hum Vaccin Immunother; 2023 Dec; 19(1):2175519. PubMed ID: 36935353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dawn of phage therapy.
    Rehman S; Ali Z; Khan M; Bostan N; Naseem S
    Rev Med Virol; 2019 Jul; 29(4):e2041. PubMed ID: 31050070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage-layer interferometry: a companion diagnostic for phage therapy and a bacterial testing platform.
    Needham P; Page RC; Yehl K
    Sci Rep; 2024 Mar; 14(1):6026. PubMed ID: 38472239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.